The accuracy of non-invasive blood and stool-based tests for colorectal cancer is improving, but experts say it’s too soon to ...

The FDA approved ustekinumab-aekn (Selarsdi) injection as an interchangeable biosimilar to Stelara for the treatment of Crohn's disease and UC, among other indications, drugmakers Teva Pharmaceuticals ...

Please provide your email address to receive an email when new articles are posted on . Higher fecal hemoglobin concentrations at baseline suggest a shorter repeat screening interval. Screening ...

The FDA approved the Shield blood test for colorectal cancer (CRC) screening in adults ages 45 and older at average risk for the disease, Guardant Health announced. According to the company, the ...

Over a 20-year period, colorectal cancer screening rates approximately doubled and mortality declined across all racial groups following systematic outreach. Colorectal cancer (CRC) screening rates ...

Blood-based screening for colorectal cancer (CRC) should only be used with patients who are not completing other endorsed screening options, according to a study. This study aimed to use a simulation ...

– Data Presented at DDW 2019 Show 93.6% Acceptance Rate Among Patients Unwilling or Unable to Complete Other CRC Screening Tests – BERLIN and SAN DIEGO, May 19, 2019 (GLOBE NEWSWIRE) -- Epigenomics AG ...

Please provide your email address to receive an email when new articles are posted on . Annual fecal immunochemical testing was the most effective and cheapest CRC screening method for underserved ...

A newly developed quality performance measure that tracks completion of colorectal cancer (CRC) screening with a colonoscopy within 6 months of an abnormal stool-based screening test (SBT) in adults ...

A mailed fecal immunochemical test (FIT) outreach followed by patient navigation for those with a positive test increased colorectal cancer (CRC) screening participation at 6 months compared with ...

As colorectal cancer cases continue to grow in young patients nationwide, screening these patients continues to face setbacks. One major setback in CRC screening was the COVID-19 pandemic. Two small ...

“In conclusion, our study highlights that rural–urban disparities in colorectal cancer screening persist in the United States, with most of the difference driven by unmeasured factors beyond ...